openPR Logo
Press release

Single Agent Chemotherapy Market to Receive Overwhelming Hike in Revenues by 2024

08-20-2020 12:37 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Single Agent Chemotherapy Market: Snapshot

The idea of creating a singular therapeutic drug for multiple forms of cancer has been a widely coveted topic in the healthcare industry. Multiple agents have so far been explored as prime contenders for single agent chemotherapy, especially for esophageal cancer and breast cancer. Currently, for esophageal cancer, single agent chemotherapy has been observed to have short lived responses, which is one of the primary reasons for the greater proportion of usage of combinational chemotherapy. A large number of drug combinations in esophageal chemotherapy are based off cisplatin. A similar case is currently made in favor of combinational chemotherapy for metastatic breast cancer, where research shows that combination chemotherapy gives better overall results than the sequential treatment of a patient using single agents.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3953

However, the benefits of combinational chemotherapy do not suffice to answer for the massive risks or side effects that they hold. Combinational chemotherapy is known to hold a much higher rate of toxicity than single agent chemotherapy. The impact of the former is also largely negative on the mental health of a patient along with their social life. This implies a chance of a lower quality of life for the patient after chemotherapy with combination chemotherapy than with single agent chemotherapy.

Single agent chemotherapy refers to the treatment of cancer with a potent single chemotherapy drug instead of multiple chemotherapy agents. Though, the combination chemotherapy is standard treatment method in most of cancer cases, increasing burden of high risk side effects and adverse effects of combination therapy has promoted use of single agent in management of cancer. Single agent chemotherapy offers some advantages as compared to combination chemotherapy treatment such as in reducing negative effects on quality of life by minimizing toxicity and unwanted side effects. Sequential single-agent treatment is also gaining popularity because of the potential merits associated with single-agent chemotherapy. Single agent chemotherapy also allows for greater dose intensity of drug in some severe conditions.

High incidence of life threatening adverse effects in many cases of combination therapy and high cost of treatment associated with multiple agents are some of the major drivers of single agent chemotherapy market. Rising number of cancer cases globally will further enhance the growth of this market since chemotherapy is considered to be one of the most effective treatments of the cancer. According to the Cancer Research U.K., 14.1 million cancer cases were recorded globally in 2012 alone in the U.K. In addition, factors such as less toxicity and impairment of quality of life have widened the acceptance of single agent chemotherapy amongst patients. Furthermore, huge investment in research and development by pharmaceutical companies, extensive academic and industry collaborations and innovation in targeted drug delivery technologies have shown immense possibilities in future growth of single agent chemotherapy market. However, increasing resistance against single chemotherapy agent over the course of treatment and delayed tumor response rate as compared to combination therapy are some of the key factors restraining the growth of single agent chemotherapy.

Request for Analysis of COVID19 Impact on Single Agent Chemotherapy Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3953

The global single agent chemotherapy market has been segmented on the basis of major drug classes, type of cancer and chemotherapy drugs. Major classes of single agent chemotherapy drugs are alkylating agents, anti-tumor antibiotics, mitotic inhibitors, antimetabolites and miscellaneous single chemotherapy drugs. Alkylating agents is the largest segment of single agent chemotherapy market. By type of cancer, single agent chemotherapy market has been segmented into brest cancer, lung cancer, gastrointestinal cancer, genitourinary cancer, head & neck cancer, endocrine cancer, gynecologic cancers, blood cancer, brain cancer and others. Brest cancer constituted the largest segment by type of cancer for single agent chemotherapy market in 2013. Some of the most popular single agent chemotherapy drugs include chlorambucil, fludarabine, bendamustine, mitomycin, teniposide, vinblastine, carboplatin, dacarbazine, procarbazine, doxorubicin, ramucirumab, ado-trastuzumab and imatinib.

Based on geography, the single agent chemotherapy market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region was recognized as the largest single agent chemotherapy market across the globe in 2013, followed by Europe. Ongoing robust research activities for the development of drugs and biologics, high prevalence of cancer and astronomically high healthcare expenditure are some of the major driving factors for growth in these regions. Cancer is the second most common cause of death in the U.S. The National Institutes of Health estimated overall costs of cancer in 2010 at USD 157 billion. Asia-Pacific is expected to be a one of the fastest growing markets during the forecast period from 2014 to 2020. This high growth is primarily due to improving economic condition in countries such as India, China and Malaysia, and large population base in Asia-Pacific region.


Purchase Single Agent Chemotherapy Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=3953<ype=S
Some of the key players operating in this market globally include Sanofi-Aventis, Novartis Pharmaceuticals, Pfizer Inc., Eli Lilly & Co, ImClone Systems Inc., GlaxoSmithKline AstraZeneca, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceuticals Industries and Roche.

Read More Reports: https://www.prnewswire.com/news-releases/rising-demand-for-techniques-in-hospitals-forms-key-revenue-generator-for-vertebroplasty-and-kyphoplasty-market-observes-tmr-301076667.html

Contact

Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Single Agent Chemotherapy Market to Receive Overwhelming Hike in Revenues by 2024 here

News-ID: 2117464 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Single

GéNIA to Release 'Jean' Single
Press Release 6 May 2021 Single Release: ‘Jean’ by GéNIA Release Date: 7 May 2021 Label: GéNIA MUSIC Genre: Classical-Crossover; Classical Solo Piano The slightly murky feeling of ‘Jean’, a peaceful piano composition, is a fond memory of the French child, the son of GéNIA’s friends, who had a very playful, slightly delicate and creative nature; he played the piano, built sand-castles, read books and even cooked, but
Single Cell Analysis Market
Single Cell Analysis Market Size Worth $ 4,752.19 Million By 2026 | CAGR: 18.4% The global Single Cell Analysis market size is expected to reach USD 4,752.19 million by 2026 according to a new study by WhipSmart MI Research. The report “Single Cell Analysis Market By Product (Consumables and Instruments), Cell Type (Human, Microbial and Animal), Technique (Flow Cytometers, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry and Other Techniques), Application
Global Single Photon Detectors Market Forecast 2018-2025 Photek, Single Quantum, …
A detailed market study on "Global Single Photon Detectors Market" examines the performance of the Single Photon Detectors market. It encloses an in-depth Research of the Single Photon Detectors market state and the competitive landscape globally. This report analyzes the potential of Single Photon Detectors market in the present and the future prospects from various angles in detail. The Global Single Photon Detectors Market 2018 report includes Single Photon Detectors market
03-23-2017 | Health & Medicine
TMR
Single-use Bioprocessing Systems Market: Demand for Customized Single-use Produc …
The highly consolidated single-use bioprocessing market is dominated by Thermo Fisher Scientific, Satorius AG, Merck KGaA, Pall Corporation, and GE Healthcare. Cumulatively, these companies accounted for a whopping 95.2% share in 2015, signaling the concentrated nature of the market by large and established players. Transparency Market Research notes that the threat of new entrants in the single-use bioprocessing systems market is moderate owing to the fact that existing players possess
Research Report Explores the Single-cell Analysis Market Single-cell Analysis Ma …
The global single-cell analysis market is emerging as a space that has whetted investors’ interest. This is attributable to the market having surmounted numerous challenges associated with sample preparation and data analysis. Moreover, continuous and rapid developments in the field of single-cell analysis research have led to the emergence of new technologies, application areas, and consumables. The single-cell analysis market began to take shape after evidence emerged that even within small
Research Report Explores the Single-cell Analysis Market Single-cell Analysis Ma …
The global single-cell analysis market is emerging as a space that has whetted investors’ interest. This is attributable to the market having surmounted numerous challenges associated with sample preparation and data analysis. Moreover, continuous and rapid developments in the field of single-cell analysis research have led to the emergence of new technologies, application areas, and consumables. The single-cell analysis market began to take shape after evidence emerged that even within small